References
- Yoneda KY, Louie S, Shelton DK. Approach to pulmonary metastases. Curr Opin Pulm Med 2000;6:356-63 https://doi.org/10.1097/00063198-200007000-00018
- Koss LG. Melamed MR. Koss' Diagnostic Cytology And Its Histopathologic Bases: Tumors of the lung. 5th edition. Lippincott Williams & Wilkins, 2005
- Koss LG, Melamed MR, Goodner JT. Pulmonary Cytology-a brief survey of diagnostic results from July 1st 1952 until December 31st, 1960. Acta Cytol 1964;8:104-13
- Giardini R, Martelli G, Rilke F, Pilotta S. Diagnostic problems of second primary malignancies detected by fine-needle aspiration cytology. Cancer 1993;72:2716-22 https://doi.org/10.1002/1097-0142(19931101)72:9<2716::AID-CNCR2820720932>3.0.CO;2-A
- Tan D, Zander DS. Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update. Int J Clin Exp Pathol 2008:1:19-31
- McCormack PM, Attiyeh FF. Resected pulmonary metastases from colorectal cancer. Dis Colon Rectum 1979;22:553- 6 https://doi.org/10.1007/BF02587003
- Schulten MF, Heiskell CA, Shields TW. The incidence of solitary pulmonary metastasis from carcinoma of the large intestine. Surg Gynecol Obstet 1976;143:727-9
- Flint A, Lloyd RV. Colon carcinoma metastatic to the lung. Cytologic manifestations and distinction from primary pulmonary adenocarcinoma. Acta Cytol 1992;36:230-5
- Koizumi JH, Schron DS. Cytologic features of colonic adenocarcinoma. Differences between primary and metastatic neoplasms. Acta Cytol 1997;41:419-26 https://doi.org/10.1159/000332534
- Sack MJ, Roberts SA. Cytokeratins 20 and 7 in the differential diagnosis of metastatic carcinoma in cytologic specimens. Diagn Cytopathol 1997;16:132-6 https://doi.org/10.1002/(SICI)1097-0339(199702)16:2<132::AID-DC7>3.0.CO;2-J
- Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Cancer 2001;93:330-6 https://doi.org/10.1002/cncr.9048
- Liu J, Farhood A. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations. Cancer 2004;102:109-14 https://doi.org/10.1002/cncr.20110
- David D. Diagnostic Immunohistochemistry: Immunohistology of lung and pleural neoplasms. Second edition. Churchill Livingstone, 2006
- Di Nunno L, Larsson LG, Rinehart JJ, Beissner RS. Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection. Arch Pathol Lab Med 2000;124:1467-70
- Loy TS, Chapman RK, Diaz-Arias AA, Bulatao IS, Bickel JT. Distribution of BCA-225 in adenocarcinomas. An immunohistochemical study of 446 cases. Am J Clin Pathol 1991;96: 326-9 https://doi.org/10.1093/ajcp/96.3.326
- Brown RW, Campagna LB, Dunn JK, Cagle PT. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. Am J Clin Pathol 1997;107:12- 9 https://doi.org/10.1093/ajcp/107.1.12
- Ciampa A, Fanger G, Khan A, Rock KL, Xu B. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas. Cancer 2004;102:368-72 https://doi.org/10.1002/cncr.20627
- Copeland JN, Amin MB, Humphrey PA, Tamboli P, Ro JY, Gal AA. The morphologic spectrum of metastatic prostatic adenocarcinoma to the lung: special emphasis on histologic features overlapping with other pulmonary neoplasms. Am J Clin Pathol 2002;117:552-7 https://doi.org/10.1309/PCND-T3N0-5K01-D454
- Renshaw AA, Nappi D, Cibas ES. Cytology of metastatic adenocarcinoma of the prostate in pleural effusions. Diagn Cytopathol 1996;15:103-7 https://doi.org/10.1002/(SICI)1097-0339(199608)15:2<103::AID-DC4>3.0.CO;2-J
- Parwani AV, Ali SZ. Prostatic adenocarcinoma metastases mimicking small cell carcinoma on fine-needle aspiration. Diagn Cytopathol 2002;27:75-9 https://doi.org/10.1002/dc.10146
- Ordonez NG. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 2003;27:1031-51 https://doi.org/10.1097/00000478-200308000-00001
- Memeo L, Jhang J, Assaad AM, et al. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma. Am J Clin Pathol 2007;127:225-9 https://doi.org/10.1309/9KWEA4W9Y94D1AEE
- Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma. Pathol Int 2007;57:190-9 https://doi.org/10.1111/j.1440-1827.2007.02080.x
- McGregor DK, Khurana KK, Cao C, et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'. Am J Surg Pathol 2001;25:1485-92 https://doi.org/10.1097/00000478-200112000-00003
- Gokden N, Mukunyadzi P, James JD, Gokden M. Diagnostic utility of renal cell carcinoma marker in cytopathology. Appl Immunohistochem Mol Morphol 2003;11:116-9 https://doi.org/10.1097/00129039-200306000-00004
- Simsir A, Chhieng D, Wei XJ, Yee H, Waisman J, Cangiarella J. Utility of CD10 and RCCma in the diagnosis of metastatic conventional renal-cell adenocarcinoma by fine-needle aspiration biopsy. Diagn Cytopathol 2005;33:3-7 https://doi.org/10.1002/dc.20272
- Renshaw AA, Haja J, Wilbur DC, Miller TR. Fine-needle aspirates of hepatocellular carcinoma that are misclassified as adenocarcinoma: correlating cytologic features and performance in the College of American Pathologists Nongynecologic Cytology Program. Arch Pathol Lab Med 2006;130:19-22
- Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000;13:962-72 https://doi.org/10.1038/modpathol.3880175
- Onofre AS, Pomjanski N, Buckstegge B, Bocking A. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies. Cancer 2007;111:259-68 https://doi.org/10.1002/cncr.22768
- Siddiqui MT, Saboorian MH, Gokaslan ST, Ashfaq R. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples. Cancer 2002;96:49-52 https://doi.org/10.1002/cncr.10311
- Sugitani I, Fujimoto Y, Yamamoto N. Papillary thyroid car- cinoma with distant metastases: survival predictors and the importance of local control. Surgery 2008;143:35-42 https://doi.org/10.1016/j.surg.2007.06.011
- Chen C, Hoda RS, Hoda SA. Intranuclear cytoplasmic inclusions in the differential diagnosis of papillary thyroid carcinoma and bronchioloalveolar carcinoma. Diagn Cytopathol 1998;18:384-6 https://doi.org/10.1002/(SICI)1097-0339(199805)18:5<384::AID-DC19>3.0.CO;2-E
- Goldstein NS, Thomas M. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies. Am J Clin Pathol 2001;116:319-25 https://doi.org/10.1309/550P-QLJX-D84W-F6DN
- Gaeta M, Volta S, Scribano E, Loria G, Vallone A, Pandolfo I. Air-space pattern in lung metastasis from adenocarcinoma of the GI tract. J Comput Assist Tomogr 1996;20:300-4 https://doi.org/10.1097/00004728-199603000-00025
- Geurts TW, Nederlof PM, van den Brekel MW, et al. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary? Clin Cancer Res 2005;11:6608-14 https://doi.org/10.1158/1078-0432.CCR-05-0257
- Renshaw AA, Madge R. Cercariform cells for helping distinguish transitional cell carcinoma from non-small cell lung carcinoma in fine needle aspirates. Acta Cytol 1997;41:999-1007 https://doi.org/10.1159/000332779
- Johnson TL, Kini SR. Cytologic features of metastatic transitional cell carcinoma. Diagn Cytopathol 1993;9:270-8 https://doi.org/10.1002/dc.2840090306
- Layfield LJ, Jones C, Hirschowitz S. Statistical analysis of cytologic features useful in separation of metastatic urothelial carcinoma from other metastatic epithelial malignancies. Diagn Cytopathol 2003;29:334-8 https://doi.org/10.1002/dc.10380
- Renshaw AA, Madge R, Granter SR. Intracytoplasmic eosinophilic inclusions (Melamed-Wolinska bodies). Association with metastatic transitional cell carcinoma in pleural fluid. Acta Cytol 1997;41:995-8 https://doi.org/10.1159/000332778
- Bassily NH, Vallorosi CJ, Akdas G, Montie JE, Rubin MA. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Am J Clin Pathol 2000;113:383-8 https://doi.org/10.1309/G1RA-EU9X-X6VV-3W79
- Moll R, Laufer J, Wu XR, Sun TT. Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas. Verh Dtsch Ges Pathol 1993;77:260-5
- Kaufmann O, Volmerig J, Dietel M. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol 2000;113:683-7 https://doi.org/10.1309/PYQC-17CB-063T-Q07J
- Langner C, Ratschek M, Tsybrovskyy O, Schips L, Zigeuner R. P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors. J Histochem Cytochem 2003; 51:1097-9 https://doi.org/10.1177/002215540305100813
- Shin HJ, Caraway NP. Fine-needle aspiration biopsy of metastatic small cell carcinoma from extrapulmonary sites. Diagn Cytopathol 1998;19:177-81 https://doi.org/10.1002/(SICI)1097-0339(199809)19:3<177::AID-DC4>3.0.CO;2-A
- Kim K, Naylor B, Han IH. Fine needle aspiration cytology of sarcomas metastatic to the lung. Acta Cytol 1986;30:688- 94